Skip to main content
. 2017 Mar 3;7(3):e015358. doi: 10.1136/bmjopen-2016-015358

Table 2.

Suggested fluid challenges and use of vasoconstrictor therapy if there was evidence of fluid responsiveness

Colloid* (recommended) or crystalloid (3 mL/kg) Liberal Restrictive
Colloid/blood (using a transfusion threshold) bolus if acute bleeding Yes Yes
If normotensive but monitoring suggests hypovolaemia (eg, CVP<5 or oliguria) Yes No
If normotensive but goal-directed device suggests hypovolaemia (eg, FTc <0.33, ΔSV ≥10% or SVV≥13%) Yes Consider
If hypotensive
(1) and hypovolaemia Colloid* Colloid* (but limit)+vasoconstrictor
(2) but not hypovolaemic Colloid*±vasoactive vasoactive therapy

*Starch-based colloids were not recommended.

CVP, central venous pressure monitoring; FTc, flow time corrected; SVV, stroke volume variation.